Different alterations of SOCS1 expression contribute to this mechanism, beginning with SOCS1 silencing through hypermethylation of its promoter region, observed in diverse malignant diseases such as pancreatic carcinoma, acute myeloid leukemia, and hepatocellular carcinoma (HCC) (13). This evidence concerns the gene SOCS1 and hepatocellular carcinoma.